Valuation: Microba Life Sciences Limited

Market Cap 25.21M 17M 15.43M 14.26M 12.86M 24.28M 1.59B 172M 67.95M 857M 63.79M 62.44M 2.71B P/E 2027 *
-
P/E 2028 * -
Enterprise Value 22.61M 15.25M 13.84M 12.79M 11.54M 21.78M 1.42B 154M 60.94M 769M 57.21M 56M 2.43B EV / Sales 2027 *
1.47x
EV / Sales 2028 * 1.15x
Free-Float
61.55%
Yield 2027 *
-
Yield 2028 * -
1 day+2.86%
1 week+2.86%
Current month+4.35%
1 month-12.20%
3 months-33.33%
6 months-53.25%
Current year-52.63%
1 week 0.04
Extreme 0.035
0.04
1 month 0.03
Extreme 0.033
0.04
Current year 0.03
Extreme 0.033
0.1
1 year 0.03
Extreme 0.033
0.1
3 years 0.03
Extreme 0.033
0.32
5 years 0.03
Extreme 0.033
0.45
10 years 0.03
Extreme 0.033
0.45
Manager TitleAgeSince
Chief Executive Officer - 29/09/2026
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 01/01/2024
Director TitleAgeSince
Director/Board Member - 31/01/2017
Director/Board Member - -
Chairman - -
Date Insider Type Main position Quantity % Market Cap. Importance
19/11/24 Buy

Chairman

100,000 0.0223%
19/11/24 Buy

Chairman

100,000 0.0223%
19/11/24 Buy

Director

200,000 0.0447%
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%+2.86%-50.68%-84.35% 17.02M
-3.14%-3.60%+9.44%+24.71% 113B
-2.07%-0.64%+5.05%+103.42% 107B
-0.35%-7.86%+39.52%+437.13% 41.83B
+0.45%+0.73%+10.26%+97.14% 33.39B
-1.13%-0.71%+40.89%+73.93% 30.24B
-2.23%-0.81%+37.68%+90.04% 28.85B
-3.25%-2.82%+46.61%+342.53% 23.2B
+0.33%-1.21%-17.53%-19.48% 19.72B
-1.13%+1.81%-4.02%+32.27% 17.18B
Average -0.97%-1.57%+11.72%+109.73% 41B
Weighted average by Cap. -1.84%-2.28%+15.90%+116.56%

Financials

2027 *2028 *
Net sales 15.36M 10.36M 9.4M 8.69M 7.84M 14.79M 968M 105M 41.39M 522M 38.86M 38.04M 1.65B 19.78M 13.34M 12.11M 11.19M 10.09M 19.05M 1.25B 135M 53.31M 673M 50.05M 48.99M 2.12B
Net income - -
Net Debt -2.6M -1.75M -1.59M -1.47M -1.33M -2.5M -164M -17.72M -7.01M -88.4M -6.58M -6.44M -279M -2.5M -1.69M -1.53M -1.41M -1.28M -2.41M -158M -17.04M -6.74M -85M -6.33M -6.19M -269M
Projected Income Statement - Annual - Microba Life Sciences Limited
Logo Microba Life Sciences Limited
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.
Employees
-
Date Price Change Volume
13/11/26 A$0.0360 +2.86% 82,640
12/11/26 A$0.0350 0.00% 61,649
11/11/26 A$0.0350 0.00% 133,761
10/11/26 A$0.0350 +2.94% 60,046
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0360AUD
Average target price
0.0822AUD
Spread / Average Target
+128.31%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Microba Life Sciences Limited